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Method
Two groups of participants were recruited:
Community group
We recruited a community group of both genders who were either planning or very motivated to have a cosmetic procedure in the future. The questionnaire was completed by n Z 108 participants.
BDD group
A psychiatrist conducted an interview based on DSM-IV to diagnose BDD in a clinical setting. Ninety-seven patients with BDD seeking a cosmetic procedure were recruited. All participants completed the following:
The questionnaire asks for the feature(s) that the person finds unattractive, the nature of the cosmetic procedures they are seeking and diagnostic criteria of BDD. The final version of COPS questionnaire comprises 9 items. Items are scored from 0 (least impaired) to 8 (most impaired). The scale and a full version of this paper are available to download from: http://www.iop. kcl.ac.uk/cadatquestionnaire. The score is achieved by summing Q 2-10. Items 2, 3 and 5 are reversed. The total ranges from 0 to 72 with a higher score reflecting greater impairment.
2) Hospital Anxiety and Depression Scale (HAD) 3) Body Image Quality of Life Inventory (BIQLI) 4) Body Image Disturbance Questionnaire (BIDQ)

Results
Items on the COPS that showed a significant difference between the two groups, which did not have a significant group Â sex interaction and had an effect size (Cohen's d) of at least 0.80 were retained in the item discriminatory analysis. Nine items met these criteria and were used to form the final questionnaire (see Table 1 ).
Internal consistency
Reliability analysis resulted in an internal consistency of Cronbach's a Z 0.91 with corrected item total ranging from 0.41 to 0.86. 
Test-retest reliability
Convergent validity
Based on the data from both groups the COPS correlated highly with the HAD depression subscale (r Z 0.7, p < 0.01) and anxiety subscale (r Z 0.66, p < 0.01). COPS also correlated highly with the BIQLI (r Z -0.68, p < 0.01). Thus higher scores on COPS are associated with lower body image quality of life. Figure 1 represents the ROC curve for BDD patients compared with community controls. The area under the curve (AUC) for this analysis was 0.905 (95% CI Z 0.862e0.948) indicating that the COPS is an accurate diagnostic test. Based on the discrimination of BDD patients from the community group, a cut-off value of !40 resulted in a maximal kappa coefficient (k Z 0.69, p < 0.001). On the basis of this cut-off value, 88.9% of BDD patients and 80.6% of the community group were classified correctly.
Cut-off value and ROC analysis
Sensitivity to change
We examined sensitivity to change in a sub-sample of 5 patients with BDD who were undergoing cognitive behaviour therapy. 3, 4 Scores on the COPS were examined at baseline, 6 weeks, and 12 weeks. The mean and SD on the 9-item COPS was 52.40 (SD Z 16.70) at baseline and 35.00 (SD Z 22.88) at 12 weeks. A one-way repeated measures ANOVA was conducted to compare scores across these 3 treatment points. There was a significant effect across the 3 treatment points [F (1.10, 4.38) Z 7.35, p Z 0.047].
Discussion
We have developed a brief (nine item) screening questionnaire (COPS) that can be used in a cosmetic procedure setting to screen patients with BDD. The scale has acceptable internal consistency, test-retest reliability, and convergent validity. It has a high sensitivity for the diagnosis of BDD in people who are likely to seek a cosmetic procedure. Individuals who score 40 or more should be referred for further assessment. The COPS was also sensitive to change in patients receiving cognitive behaviour therapy. 3, 4 It may therefore be used an outcome measure after any treatment (including cosmetic procedures) to determine (a) if there is any improvement in symptoms of BDD on a continuous dimension (b) whether it may predict persistence of symptoms or dissatisfaction with a cosmetic procedure (in the absence of any surgical complications). 
